VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Loans
Loans
Jump to
  • Buy Lupin; target of Rs 1085: Prabhudas Lilladher

    Buy Lupin; target of Rs 1085: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated August 25, 2020.

  • Lupin: At the inflection point for complex generics

    Lupin: At the inflection point for complex generics

    The traction in complex generic products and the restructuring initiatives can accelerate earnings growth for Lupin

  • Buy Lupin; target of Rs 979; KRChoksey

    Buy Lupin; target of Rs 979; KRChoksey

    KRChoksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 979 in its research report dated August 11, 2020.

  • Buy Lupin; target of Rs 1015: Motilal Oswal

    Buy Lupin; target of Rs 1015: Motilal Oswal

    Motilal Oswal is bullish on Lupin recommended buy rating on the stock with a target price of Rs 1015 in its research report dated August 08, 2020.

  • Hold Lupin; target of Rs 905: Emkay Global Financial

    Hold Lupin; target of Rs 905: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Lupin with a target price of Rs 905 in its research report dated August 08, 2020.

  • Buy Lupin; target of Rs 980: HDFC Securities

    Buy Lupin; target of Rs 980: HDFC Securities

    HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 980 in its research report dated August 10, 2020.

  • Buy Lupin; target of Rs 1030: ICICI Direct

    Buy Lupin; target of Rs 1030: ICICI Direct

    ICICI Direct is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 09, 2020.

  • Lupin: Execution for US portfolio a key monitorable

    Lupin: Execution for US portfolio a key monitorable

    Lupin's guidance for the portfolio rollout in the US market is encouraging. New launches and an improving market share in Levothyroxine are expected to help tide over structural pricing erosion in the near to medium term

  • Sell Lupin; target of Rs 753: Dolat Capital

    Sell Lupin; target of Rs 753: Dolat Capital

    Dolat Capital is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 753 in its research report dated August 08, 2020.

  • Buy Lupin; target of Rs 1001: Prabhudas Lilladher

    Buy Lupin; target of Rs 1001: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1001 in its research report dated August 08, 2020.

  • Hold Lupin; target of Rs 965: Sharekhan

    Hold Lupin; target of Rs 965: Sharekhan

    Sharekhan recommended Hold rating on Lupin with a target price of Rs 965 in its research report dated August 07, 2020.

  • Sell Lupin; target of Rs 753: Dolat Capital

    Sell Lupin; target of Rs 753: Dolat Capital

    Dolat Capital is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 753 in its research report dated July 24, 2020.

  • Hold Lupin; target of Rs 905: Emkay Global Financial

    Hold Lupin; target of Rs 905: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Lupin with a target price of Rs 905 in its research report dated May 30, 2020.

  • Hold Lupin; target of Rs 930: ICICI Direct

    Hold Lupin; target of Rs 930: ICICI Direct

    ICICI Direct recommended hold rating on Lupin with a target price of Rs 930 in its research report dated May 31, 2020.

  • Buy Lupin; target of Rs 1000: Motilal Oswal

    Buy Lupin; target of Rs 1000: Motilal Oswal

    Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated May 30, 2020.

  • Sell Lupin; target of Rs 750: Dolat Capital

    Sell Lupin; target of Rs 750: Dolat Capital

    Dolat Capital is bearish on Lupin has recommended sell rating on the stock with a target price of Rs 750 in its research report dated May 30, 2020.

  • Hold Lupin target of Rs 940: Sharekhan

    Hold Lupin target of Rs 940: Sharekhan

    Sharekhan recommended Hold rating on Lupin with a target price of Rs 940 in its research report dated May 29, 2020.

  • Buy Lupin; target of Rs 1001: Prabhudas Lilladher

    Buy Lupin; target of Rs 1001: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1001 in its research report dated May 30, 2020.

  • Lupin: A watershed year for the US business?

    Lupin: A watershed year for the US business?

  • Buy Lupin; target of Rs 978: Prabhudas Lilladher

    Buy Lupin; target of Rs 978: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 978 in its research report dated May 10, 2020.

  • Pharma companies that can benefit from the demand for complex respiratory drugs

    Pharma companies that can benefit from the demand for complex respiratory drugs

  • Hold Lupin; target of Rs 675: ICICI Direct

    Hold Lupin; target of Rs 675: ICICI Direct

    ICICI Direct recommended hold rating on Lupin with a target price of Rs 675 in its research report dated February 11, 2020.

  • Hold Lupin; target of Rs 760: Prabhudas Lilladher

    Hold Lupin; target of Rs 760: Prabhudas Lilladher

    Prabhudas Lilladher recommended hold rating on Lupin with a target price of Rs 760 in its research report dated December 19, 2019.

  • Hold Lupin; target of Rs 760: Prabhudas Lilladher

    Hold Lupin; target of Rs 760: Prabhudas Lilladher

    Prabhudas Lilladher recommended Hold rating on Lupin with a target price of Rs 760 in its research report dated November 13, 2019.

  • Hold Lupin; target of Rs 720: ICICI Direct

    Hold Lupin; target of Rs 720: ICICI Direct

    ICICI Direct recommended hold rating on Lupin with a target price of Rs 720 in its research report dated November 07, 2019.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347